|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
ReVision Optics, Inc. Appoints Internationally Recognized Ophthalmologist Dr. Stephen G. Slade to its Board of Directors
4/23/2012 11:53:29 AM
LAKE FOREST, Calif.--(BUSINESS WIRE)--ReVision Optics®, Inc. (RVO), a leader in implantable microlens technology to treat presbyopia, today announced the appointment of the esteemed vision correction expert Stephen Slade, M.D., FACS, to the Company’s Board of Directors. “Dr. Slade is a major force in the field of ophthalmology and a renowned expert in treating patients who require vision correction such as presbyopia. We are delighted to have him join our Board and look forward to his contributions,” said J. Randy Alexander, Chairman of the Board of ReVision Optics. “Dr. Slade has pioneered many of the latest technologies for vision correction in use today. Eye surgery patients from around the world seek his professional services and, remarkably, more than 450 of his fellow eye surgeons have chosen him to perform surgery on them. Dr. Slade brings to ReVision Optics a wealth of knowledge, regulatory expertise and industry contacts that will be highly beneficial as we pursue FDA approval to market our PresbyLens® microlens.”
|
|
|
|
|
|
|
|
|
|
|